73 related articles for article (PubMed ID: 34879787)
1. Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer.
Ladekarl M; Rasmussen LS; Kirkegård J; Chen I; Pfeiffer P; Weber B; Skuladottir H; Østerlind K; Larsen JS; Mortensen FV; Engberg H; Møller H; Fristrup CW
Acta Oncol; 2022 Mar; 61(3):277-285. PubMed ID: 34879787
[TBL] [Abstract][Full Text] [Related]
2. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
4. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
5. Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.
Go RS; Al-Hamadani M; Shah ND; Crowson CS; Holton SJ; Habermann EB
Cancer; 2016 Aug; 122(16):2552-9. PubMed ID: 27182831
[TBL] [Abstract][Full Text] [Related]
6. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2021 Apr; 21(1):387. PubMed ID: 33836694
[TBL] [Abstract][Full Text] [Related]
7. Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma.
Go RS; Bartley AC; Crowson CS; Shah ND; Habermann EB; Holton SJ; Holmes DR
J Clin Oncol; 2017 Feb; 35(6):598-604. PubMed ID: 28199819
[TBL] [Abstract][Full Text] [Related]
8. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
9. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
10. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Barzi A; Lara PN; Tsao-Wei D; Yang D; Gill IS; Daneshmand S; Klein EA; Pinski JK; Penson DF; Quinn DI; Sadeghi S
Cancer; 2019 Nov; 125(21):3853-3863. PubMed ID: 31398279
[TBL] [Abstract][Full Text] [Related]
11. Association between facility volume and mortality of patients with classic Hodgkin lymphoma.
Goyal G; Tella SH; Funni S; Kommalapati A; Inselman JW; Shah ND; Go RS; Ansell SM
Cancer; 2020 Feb; 126(4):757-764. PubMed ID: 31714588
[TBL] [Abstract][Full Text] [Related]
12. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
13. Are academic hospitals better at treating metastatic colorectal cancer?
Atallah C; Oduyale O; Stem M; Eltahir A; Almaazmi HH; Efron JE; Safar B
Surgery; 2021 Feb; 169(2):248-256. PubMed ID: 32680747
[TBL] [Abstract][Full Text] [Related]
14. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
[TBL] [Abstract][Full Text] [Related]
15. Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer.
McAllister J; Amin S; Lin C
Future Oncol; 2022 Mar; 18(10):1273-1284. PubMed ID: 35114803
[TBL] [Abstract][Full Text] [Related]
16. Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma.
Kommalapati A; Tella SH; Goyal G; Borad M; Alberts SR; Roberts L; Hubbard JM; Durgin L; Cleary S; Mahipal A
HPB (Oxford); 2019 Mar; 21(3):379-386. PubMed ID: 30266490
[TBL] [Abstract][Full Text] [Related]
17. Impact of Facility Surgical Volume on Survival in Patients With Cancer.
Stoltzfus KC; Shen B; Tchelebi L; Trifiletti DM; Gusani NJ; Walter V; Wang M; Zaorsky NG
J Natl Compr Canc Netw; 2021 May; 19(5):495-503. PubMed ID: 33561825
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract][Full Text] [Related]
19. Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer.
Carnie L; Abraham M; McNamara MG; Hubner RA; Valle JW; Lamarca A
Pancreatology; 2020 Dec; 20(8):1682-1688. PubMed ID: 33046391
[TBL] [Abstract][Full Text] [Related]
20. Impact of facility type on survival after pancreatoduodenectomy for small pancreatic adenocarcinoma (≤ 2 cm).
Maegawa FB; Ashouri Y; Bartz-Kurycki M; Ahmad M; De La Rosa E; Philipovskiy A; Riall TS; Konstantinidis IT
Am J Surg; 2021 Jul; 222(1):145-152. PubMed ID: 33131577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
